Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Viela Bio Inc. (VIE)

28.2   0.12 (0.43%) 10-01 15:39
Open: 28.16 Pre. Close: 28.08
High: 29.02 Low: 27.96
Volume: 135,410 Market Cap: 1,543M
Viela Bio, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatment for autoimmune and inflammatory diseases. The company is headquartered in Gaithersburg, Maryland and currently employs 95 full-time employees. The firm is focused on developing treatments for severe inflammation and autoimmune diseases. Its product pipeline includes Inebilizumab, VIB4920 and VIB7734. Inebilizumab is a humanized mAb that binds to and depletes CD19+ B cells including plasmablasts and plasma cells. VIB4920 is a fusion protein designed to bind to CD40 ligand (CD40L) on activated T cells, blocking the interaction with CD40 expressed on B cells and preventing them from differentiating into plasma cells and memory B cells. VIB7734 is a treatment for autoimmune and related inflammatory diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 28.525 - 28.726 28.726 - 28.882
Low: 26.192 - 26.395 26.395 - 26.553
Close: 27.368 - 27.69 27.69 - 27.94

Technical analysis

as of: 2020-10-01 3:11:21 PM
Overall:       
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 38.14     One year: 43.65
Support: Support1: 25.02    Support2: 20.82
Resistance: Resistance1: 32.65    Resistance2: 37.37
Pivot: 29.50
Moving Average: MA(5): 26.97     MA(20): 30.15
MA(100): 40.77     MA(250): 36.29 -10000000000
MACD: MACD(12,26): -2.10     Signal(9): -2.02
Stochastic oscillator: %K(14,3): 20.16     %D(3): 15.38
RSI: RSI(14): 42.62
52-week: High: 70.66  Low: 18.20  Change(%): 21.4
Average Vol(K): 3-Month: 19423  10-Days: 27369

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
VIE has closed above bottom band by 41.5%. Bollinger Bands are 16.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 01 Oct 2020
Did Viela Bio's (NASDAQ:VIE) Share Price Deserve to Gain 20%? - Yahoo Finance

Wed, 30 Sep 2020
Md. firm sets terms of IPO, taps new execs and board members - Washington Business Journal

Tue, 29 Sep 2020
Do Analysts Agree on Viela Bio Inc (VIE) Stock's Target Price? - InvestorsObserver

Mon, 21 Sep 2020
-7.21% fall drives Viela Bio, Inc. (VIE) into becoming a interest-loosing stock for investors - Marketing Sentinel

Tue, 15 Sep 2020
Silver Spring regenerative medicine company Aziyo Biologics files for IPO - Washington Business Journal

Mon, 14 Sep 2020
Do Analysts Expect Viela Bio Inc (VIE) Stock to Rise? - InvestorsObserver

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 55
Shares Float (M) 20
% Held by Insiders 56.90
% Held by Institutions 37.93
Shares Short (K) 2,870
Shares Short P. Month (K) 2,100

Stock Financials

EPS -103.070
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -297.670
Profit Margin
Operating Margin -479.54
Return on Assets (ttm) -26.5
Return on Equity (ttm) -45.4
Qtrly Rev. Growth
Gross Profit (p.s.) 0.914
Sales Per Share 0.548
EBITDA (p.s.) -2.622
Qtrly Earnings Growth
Operating Cash Flow (M) -137
Levered Free Cash Flow (M) -68

Stock Valuations

PE Ratio -0.28
PEG Ratio
Price to Book value -0.10
Price to Sales 51.83
Price to Cash Flow -11.35

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.